Home › Products › Oncology › Darzalex Faspro 1800mg Injection
Darzalex Faspro 1800mg Injection
Salt Composition: DARATUMUMAB
- Manufacturer: JOHNSON & JOHNSON PVT LTD
- Pack Size: 1 VIAL(s) OF 20ML
- Dosage Form: INJECTION
- Strength: 1800MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Store Darzalex Faspro 1800mg Injection in the refrigerator (2°C to 8°C) Do not freeze Keep the injection away from the reach of children and pets. If you have missed any dosing appointments, inform your doctor and schedule immediately.
₹197322.00₹236250.00
Inclusive of all taxes
Product Introduction
Darzalex Faspro 1800mg Injection is a targeted therapy for cancer containing the active ingredient daratumumab, which belongs to the group of medicines called monoclonal antibodies. Monoclonal antibodies are proteins that recognise and attach to specific targets, killing cancer cells. It is used to treat multiple myeloma (bone marrow cancer) in adults aged 18 years or older.
Inform your doctor if you have ever had a hepatitis B infection, as this medicine may cause the hepatitis B virus to become active again. Darzalex Faspro 1800mg Injection can decrease platelet counts (involved in blood clotting) and white blood cell counts (involved in fighting infections). Do not use Darzalex Faspro 1800mg Injection if you are allergic to daratumumab or any other medicine ingredients. This medicine is not recommended for children and adolescents.
Inform your doctor if you experience any infusion-related reactions, such as swelling of the face, lips, mouth, tongue, or throat. If infusion reactions occur, additional medicine may be required, or the infusion may be slowed or stopped.
Inform your doctor if you are on a salt-controlled diet, as this medicine contains sodium. Tell your doctor if you have a history of breathing problems (asthma or chronic obstructive pulmonary disease) or have had shingles before taking Darzalex Faspro 1800mg Injection. This medicine can alter blood test results used to determine your blood type. You must inform your healthcare provider that you are being treated with this medicine before receiving blood transfusions.
Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception during treatment and for three months after treatment.
Uses
Treatment of Multiple myeloma
How it works
Daratumumab binds specifically to a protein called CD38 found on the surface of multiple myeloma cells. This binding can trigger the immune system to attack and kill the cancer cells.
How to Use
A trained doctor or nurse should only administer it. Do not self-administer the injection. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for unwanted side effects.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Infusion reactions (itching, wheezing, chills, fever, throat tightness, runny nose, headache, low pressure) Changes in blood tests Decrease in blood cell counts Common: Nausea, vomiting Back pain, muscle spasms Diarrhea Tiredness Shortness of breath Upper respiratory tract infection Tingling, numbness, or pain Constipation Trouble sleeping Dizziness Joint pain
Expert Tips
If you experience any symptoms mentioned above, consult your doctor immediately. While undergoing treatment, use effective contraception and continue it for three months after stopping treatment. This medicine is not recommended for children and adolescents under 18 years. Do not freeze the medicine. Before starting the treatment, inform your doctor about every underlying medical condition. Talk to your physician if you are on a salt-controlled diet, as this medicine contains sodium.
References
- 1. Janssen-Cilag International NV, Electronic medicines compendium (EMC), [ Revised on Feb 2023] [ Accessed on 1 May 2023], https://www.medicines.org.uk/emc/files/pil.7250.pdf 2. Janssen Biotech, Inc, US Food and Drug Administration, [ Revised on May 2018] [ Accessed on 1 May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761036s013lbl.pdf 3. Danai Dima et al.; Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy, and Place in Therapy; Cancer Management and Research; Published on 26/08/2020; Accessed on 1 May 2023; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457558/
Safety Advice
Pregnancy: Consult your doctor Your doctor will prescribe Darzalex Faspro 1800mg Injection only if needed, as this medicine might cause harm to the unborn baby. So notify your doctor before starting the preganat if you are preganat or planning to get pregnant. Use effective contraception during and after the treatment for three months.
Lungs: Consult your doctor It is unknown whether Darzalex Faspro 1800mg Injection is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms, such as difficulty breathing.
Breastfeeding: safe It is unknown whether Darzalex Faspro 1800mg Injection is safe to administer in breastfeeding patients. Before starting the treatment, notify your doctor if you are breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.